SCHEMBL10053703

SCHEMBL10053703

COc1ccc(OC(C)C(=O)N2CCc3ccccc3C2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 3/20 1.00
▸ NPC1 O15118 1/20 0.60
▸ RAB9A P51151 1/20 0.60
▸ TAAR1 Q96RJ0 1/20 0.60
▸ ACE P12821 1/20 0.55
▸ ALDH1A1 P00352 3/20 0.55
▸ L3MBTL1 Q9Y468 2/20 0.55
▸ KDM4E B2RXH2 1/20 0.55
▸ ALOX15 P16050 1/20 0.55
▸ KMT2A Q03164 1/20 0.55
▸ HSD17B10 Q99714 1/20 0.55
▸ PDE4B Q07343 1/20 0.55
▸ PDE4D Q08499 1/20 0.55
▸ SMN1; SMN2 Q16637 2/20 0.54
▸ TDP1 Q9NUW8 1/20 0.54
▸ TSHR P16473 2/20 0.53
▸ ADORA2A P29274 1/20 0.52
▸ ADORA2B P29275 1/20 0.52
▸ LMNA P02545 1/20 0.52
▸ CRHBP P24387 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10054188 0.89 HPGD (0.80) HPGDNPC1RAB9AACEALDH1A1
SCHEMBL10054189 0.89 HPGD (0.80) HPGDNPC1RAB9AACEALDH1A1
SCHEMBL20248172 0.89 HPGD (0.80) HPGDNPC1RAB9AACEALDH1A1
SCHEMBL28052479 0.79 NPC1 (0.66) HPGDNPC1RAB9ATAAR1ALDH1A1
SCHEMBL13302265 0.79 HPGD (0.69) HPGDNPC1RAB9ATAAR1ALDH1A1
SCHEMBL30260147 0.79 HPGD (0.69) HPGDNPC1RAB9ATAAR1ALDH1A1
SCHEMBL14946437 0.77 HPGD (0.63) HPGDNPC1RAB9ATAAR1ACE
SCHEMBL28655184 0.77 TDP1 (0.63) HPGDTAAR1ACEALDH1A1KDM4E
SCHEMBL12783352 0.77 ACE (0.70) HPGDNPC1RAB9ATAAR1ACE
SCHEMBL17278349 0.76 ACE (0.68) HPGDNPC1RAB9ATAAR1ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8906945-B2 Inhibitors of bacterial type III secretion system MICROBIOTIX, INC. (US) 2014-12-09 — — US disclosed
US-20120114633-A1 Inhibitors Of Bacterial Type III Secretion System NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2012-05-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120114633-A1 Inhibitors Of Bacterial Type III Secretion System CLPP, TFPI, SI HPGD 2656/4885NPC1 2916/4885RAB9A 980/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback